NASDAQ:SRTA | Free Cash Flow | Strata Critical Medical, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2019-09-30 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$3.89M$5.18M-$1.29M-60.07%
2025-12-31-$8.31M$1.85M-$10.16M
2025-03-31-$246,000.00$2.61M-$2.86M
2024-12-31-$1.75M$4.58M-$6.33M
2024-03-31-$15.55M$816,000.00-$16.37M
2023-12-31-$9.32M$24,000.00-$9.34M
2023-03-31-$16.86M$646,000.00-$17.5M
2022-12-31-$9.1M$11,000.00-$9.12M
2022-03-31-$10.07M$437,000.00-$10.5M
2021-09-30-$5.79M$67,000.00-$5.86M
2021-03-31-$605,000.00$53,000.00-$658,000.00
2020-12-31-$378,407.00
2020-09-30-$903,000.00-$4,000.00-$907,000.00
2020-03-31-$212,273.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$48.91M$9.6M-$58.51M-141.51%
2024-12-31-$2.52M$30.86M-$33.38M
2023-12-31-$32.35M$2.11M-$34.46M
2022-12-31-$37.13M$730,000.00-$37.86M
2021-09-30-$15.62M$297,000.00-$15.91M
2020-12-31-$794,467.00
2020-09-30-$10.82M$377,000.00-$11.2M
2019-09-30-$10.3M$604,000.00-$10.91M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.